SCHEMBL3012967

SCHEMBL3012967

Cc1[nH]c2ccc(Cl)cc2c1S(=O)(=O)c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.46
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
BCAT1 P54687 1/20 0.40
CSF1R P07333 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938291 0.80 MAP2 (0.55) BCAT1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3017326 0.72 AKR1B1 (0.47) PTGS2GAAHPGDMEN1KMT2A
SCHEMBL3478192 0.69 TUBB4A (0.48) PTGS2LMNAGAAHPGDCSF1R
SCHEMBL2062055 0.67 LMNA (0.57) PTGS2LMNACYP1A2GAAHPGD
SCHEMBL30547019 0.67 LMNA (0.56) LMNACYP1A2GAAHPGDTUBB4A
SCHEMBL9843379 0.67 LMNA (0.56) LMNACYP1A2GAAHPGDTUBB4A
SCHEMBL5355744 0.67 IDO1 (0.56) PTGS2LMNACYP1A2GAAHPGD
SCHEMBL3477191 0.67 FFAR2 (0.60) PTGS2CSF1RTUBB4ATUBBTUBA3C
SCHEMBL10720773 0.67 LMNA (0.56) LMNACYP1A2GAAHPGDKMT2A
SCHEMBL28145723 0.67 ADRA2A (0.51) PTGS2LMNACYP1A2GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197756-A1 Indole-3-Sulphur Derivatives ASTRAZENECA AB (SE) 2010-08-05 US disclosed
US-7723373-B2 Indole-3-sulphur derivatives ASTRAZENECA AB (SE) 2010-05-25 US disclosed
EP-1551802-B1 INDOLE-3-SULPHUR DERIVATIVES ASTRAZENECA AB (SE) 2009-12-02 EP disclosed
US-20060111426-A1 Indole-3-sulphur derivaties ASTRAZENECA AB (SE) 2006-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197756-A1 Indole-3-Sulphur Derivatives IDO1, IDO2, INMT PTGS2 534/4885LMNA 4648/4885CYP1A2 1063/4885
US-20060111426-A1 Indole-3-sulphur derivaties IDO1, IDO2, INMT PTGS2 853/4885LMNA 4699/4885CYP1A2 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.